• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEASPINE, INC INTERBODY SYSTEM; VERTERBRAL BODY P:ROSTHESIS PRODUCT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEASPINE, INC INTERBODY SYSTEM; VERTERBRAL BODY P:ROSTHESIS PRODUCT Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Pain (1994)
Event Date 12/23/2016
Event Type  Injury  
Manufacturer Narrative
No revision surgery is planned.Surgeon has elected to monitor patient at this time.There is no evidence that the device malfunctioned.It is unknown what caused the dysesthesia in the legs.It is unknown if the patient followed post-operative instructions.Patient should be cautioned against early weight bearing and premature ambulation that could lead to loosening and/or failure of the fixators or loss of reduction.It is unknown which concomitant device (if any) or part of the interbody fusion surgical procedure (if any) has caused or contributed to this event, and no conclusion can be drawn.Labeling, warning and precautions: procedures involving bone grafting can produce highly variable results.Significant vascular or neurological impairment proximal to the graft site.Severe vascular or neurological disease.Metabolic or systemic bone disorders that affect bone or wound healing.Severe degenerative bone disease.Uncooperative patients who will not or cannot follow postoperative instructions, including individuals who abuse drugs and/or alcohol.It is not intended to replace or change standard procedures for treatment of bone defects involving bone grafting and fixation.Does not possess sufficient mechanical strength to support the reduction of a graft site prior to tissue in-growth.Therefore anatomical reduction and rigid fixation in all planes should be obtained independently.Device remains in patient.
 
Event Description
On (b)(6) 2016 (b)(6) female underwent a two level transforaminal lumbar interbody fusion at l4-s1 involving cascadia interbody (k2m inc.), posterior fixation, autograft and bone void grafting biologic devices.Seven to ten days post-operatively the patient reported dysesthesia in their leg.Surgeon reported there was no pedicle screw breach, no nerve root swelling, and no emg changes.At their six week follow up visit patient was doing better but was still in pain.Surgeon has elected to monitor the patient.No medical intervention /revision surgery is planned at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTERBODY SYSTEM
Type of Device
VERTERBRAL BODY P:ROSTHESIS PRODUCT
Manufacturer (Section D)
SEASPINE, INC
5770 armada drive
carlsbad CA 92008
Manufacturer Contact
deborah silva
5770 armada drive
carlsbad, CA 92008
7602165633
MDR Report Key6337992
MDR Text Key67652654
Report Number2090010-2017-00001
Device Sequence Number1
Product Code MAX
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 01/24/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/16/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/24/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CASCADIA INTERBODY, K2MINC; EVO3 PUTTY 10CC; TRINITY ELITE MEDIUM
Patient Age31 YR
-
-